Cavidine improved ulcerative colitis by regulating the oxidation and antioxidant balance and inhibiting NF-κB signaling pathways and pro-inflammatory cytokines, such as TNF-α and IL-6, in colonic tissue [26]. This evidence concerns the gene NFKB1 and ulcerative colitis.